{"title": "Summary Reports on AEFIs of COVID-19 Vaccines", "author": null, "url": "https://www.npra.gov.my/index.php/en/health-professionals/summary-report-on-covid-19-vaccines-aefis.html", "hostname": "npra.gov.my", "description": "National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia. Malaysia Drug Control Authority", "sitename": "National Pharmaceutical Regulatory Agency (NPRA)", "date": "2023-09-09", "cleaned_text": "Summary Report on Adverse Events Following Immunisation of COVID-19 Vaccines in Malaysia This report provides summarised updates on adverse events following immunisation (AEFIs) of COVID-19 Vaccines in Malaysia. To receive the latest issues of summary report, you may join the NPRA Safety Information Mailing List by filling out the pemberian vaksin COVID-19 melebihi risikonya Summary Report on Adverse Events Following Immunisation of COVID-19 Vaccines in Malaysia (Data as of 30th Apr 2023) Introduction - How does NPRA collect adverse event reports? - How does NPRA process AEFI reports and monitor safety of COVID-19 vaccines? Total Doses of COVID-19 Vaccines Administered Rate of Reported Adverse Events - AEFI responses received via MySejahtera application - AEFI reports received via NPRA Reporting System - Booster doses - COVID-19 vaccination in children aged 5 to 11 years Adverse Events of Special Interest (AESI) Summary - Protective benefits of COVID-19 vaccination outweigh the risks Laporan Ringkas Kesan pemberian vaksin COVID-19 melebihi risikonya Summary Report on Adverse Events Following Immunisation of COVID-19 Vaccines in Malaysia (Data as of 31st Dec 2022) Introduction - How does NPRA collect adverse event reports? - How does NPRA process AEFI reports and monitor safety of COVID-19 vaccines? Total Doses of COVID-19 Vaccines Administered Rate of Reported Adverse Events - AEFI responses received via MySejahtera application - AEFI reports received via NPRA Reporting System - Booster doses - COVID-19 vaccination in children aged 5 to 11 years Adverse Events of Special Interest (AESI) Summary - Protective benefits of COVID-19 vaccination outweigh the risks Laporan Ringkas Kesan pemberian vaksin COVID-19 melebihi risikonya Summary Report on Adverse Events Following Immunisation of COVID-19 Vaccines in Malaysia (Data as of 20th Sept 2022) Introduction - How does NPRA collect adverse event reports? - How does NPRA process AEFI reports and monitor safety of COVID-19 vaccines? Total Doses of COVID-19 Vaccines Administered Rate of Reported Adverse Events - AEFI responses received via MySejahtera application - AEFI reports received via NPRA Reporting System - Booster doses - COVID-19 vaccination in children aged 5 to 11 years Adverse Events of Special Interest Summary - Protective benefits of COVID-19 vaccination outweigh the potential risks Laporan Ringkas Kesan pemberian vaksin COVID-19 melebihi risikonya Summary Report on Adverse Events Following Immunisation of COVID-19 Vaccines in Malaysia (Data as of 10th June 2022) Introduction - How does NPRA collect adverse event reports? - How does NPRA process AEFI reports and monitor safety of COVID-19 vaccines? Total Doses of COVID-19 Vaccines Administered Rate of Reported Adverse Events - AEFI responses received via MySejahtera application - AEFI reports received via NPRA Reporting System - Booster doses (PICK-B) - COVID-19 vaccination in adolescents aged 12 to 17 years - COVID-19 vaccination in children aged 5 to 11 years Adverse Events of Special Interest Summary - Protective benefits of COVID-19 vaccination outweigh the potential risks Summary Report on Adverse Events Following Immunisation of COVID-19 Vaccines in Malaysia (Data as of 11th March 2022) Introduction - How NPRA collects adverse event reports? - How NPRA processes AEFI reports and monitors safety of COVID-19 vaccines? Total Doses of COVID-19 Vaccines Administered Rate of Reported Adverse Events - AEFI responses received via MySejahtera application - AEFI reports received via NPRA Reporting System - Booster doses (PICK-B) - COVID-19 vaccination in children aged 5 to 11 years (PICKids) Adverse Events of Special Interest Summary - Protective benefits of COVID-19 vaccination outweigh the potential risks Summary Report on Adverse Events Following Immunisation of COVID-19 Vaccines in Malaysia (Data as of 31st December 2021) Introduction - How NPRA collects adverse event reports? - How NPRA processes AEFI reports and monitors safety of COVID-19 vaccines? Total Doses of COVID-19 Vaccines Administered Rate of Reported Adverse Events - AEFI responses received via MySejahtera application - AEFI reports received via NPRA Reporting System - COVID-19 vaccination in the age of 12 to 17 years - Booster doses Adverse Events of Special Interest Summary - Protective benefits of COVID-19 vaccination outweigh the potential risks Summary Report on Adverse Events Following Immunisation of COVID-19 Vaccines in Malaysia (Data as of 29th October 2021) Introduction - How NPRA collects adverse event reports? - How NPRA processes AEFI reports and monitors safety of COVID-19 vaccines? Total Doses of COVID-19 Vaccines Administered Rate of Reported Adverse Events - AEFI responses received via MySejahtera application - AEFI reports received via NPRA Reporting System Summary - Protective benefits of COVID-19 vaccination outweigh the potential risks "}